跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 35 条关于
“Seragem”
全部
35
临床试验
15
药物
5
机构
4
资讯
11
去年
Seragem's Master V7 Massage Device Receives FDA Approval for Multiple Therapeutic Indications
去年
Former Seagen CEO Leads Ottimo Pharma's Novel Cancer Immunotherapy Development
去年
Hera Biotech Acquires HeraFem Point-of-Care Cervical Cancer Diagnostic with 91% Sensitivity
去年
Seagen Secures $2.6B Deal with RemeGen for Novel HER2-Targeting Cancer Drug
5年前
Seagen Secures $2.6B Deal with RemeGen for Novel HER2-Targeting Cancer Drug
10个月前
Nurix Therapeutics Strengthens Board with Former Pfizer and Seagen Executive Roger Dansey
去年
Seagen Wins $42M Patent Verdict Against Daiichi Sankyo Over Enhertu Breast Cancer Drug
上个月
Breakthrough Properties Acquires Former Pfizer/Seagen Biomanufacturing Facility in Everett for $78 Million
8个月前
Pfizer's PADCEV Shows Strong Phase 3 Results in Bladder Cancer, Validating $43 Billion Seagen Acquisition
3个月前
Corrixr Therapeutics Names Seagen Veteran Nancy Whiting as Board Chair Ahead of CRISPR Oncology Push
第 1 页,共 2 页
上一页
下一页